October 01, 2025 a 12:39 pm
CI: Analysts Ratings - The Cigna Group
The Cigna Group, a major player in the insurance sector, is currently seeing stable analyst recommendations. The most recent data suggests a strong buy consensus among analysts, with a majority recommending a "Buy" rating. Continued management effectiveness and strategic positioning within health services have kept sentiment positive. Investors should monitor any strategic shifts that could influence future performance.
Historical Stock Grades
The latest analyst ratings for The Cigna Group reveal consistency in expert opinion with a leaning towards buy recommendations. The absence of any "Sell" ratings is noteworthy and suggests confidence in the company's market position.
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 6 | |
| Buy | 13 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over the past year, the number of analyst ratings has remained relatively stable, with a predominance in "Buy" recommendations. The consistency indicates confidence in The Cigna Group's foundational business aspects.
- Consistent analyst coverage with minor month-to-month variability.
- Slight reduction in "Strong Buy" ratings over the past year.
- Overall neutral to positive sentiment maintained throughout recent months.
Percentage Trends
Reviewing the percentage trends, there is a significant concentration on "Buy" recommendations, which demonstrates strong market confidence. However, there has been a minor shift from "Strong Buy" to "Hold," which may suggest cautious optimism amid market variations.
- Strong Buy decreased from 23% (2024-10) to 19% (2025-09).
- Buy ratings have consistently dominated, maintaining approximately 40%.
- Hold positions increased slightly, reflecting cautious market watchfulness.
Latest Analyst Recommendations
The latest set of recommendations shows stability in ratings, with no significant departures from existing opinions. Analysts maintain their positions, reinforcing existing confidence levels.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-09-04 | Overweight | Overweight | Barclays |
| 2025-08-26 | Overweight | Overweight | Cantor Fitzgerald |
| 2025-08-14 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-08-14 | Outperform | Outperform | Baird |
| 2025-08-04 | Buy | Buy | Guggenheim |
Analyst Recommendations with Change of Opinion
Changes in analyst opinions have been infrequent, suggesting well-rooted conviction in market analysis. Positive shifts such as upgrades may point to growth prospects and reinforce existing portfolios.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2024-02-05 | Outperform | Sector Perform | RBC Capital |
| 2024-02-05 | Overweight | Neutral | Cantor Fitzgerald |
| 2024-02-01 | Buy | Hold | Deutsche Bank |
| 2024-01-04 | Outperform | Market Perform | Bernstein |
| 2023-12-11 | Buy | Hold | Jefferies |
Interpretation
The analyst ratings for The Cigna Group indicate strong market confidence, with many leaning towards "Buy" recommendations. The overriding sentiment is one of stability, with infrequent changes signaling deep-rooted investor confidence. While there is a slight trend towards increased cautiousness, the overall sentiment appears to be positive, with analysts maintaining their previously optimistic outlook.
Conclusion
In summary, The Cigna Group is experiencing a predominantly favorable outlook from analysts, mainly supported by their strong market position and strategic initiatives. While caution may arise about minor shifts in rating categories, significant sentiment remains robust and steadfast. Analysts seem to exhibit growing confidence in Cigna's ability to handle market challenges and achieve promising growth, marking the stock as a potentially stable investment with modest risks and substantial opportunities.